A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers

Study Identifier
M25-478
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Recruitment Complete
Sign up for trial alerts

Study Details

Medical Condition
  • Healthy Volunteer
  • Study Drug
  • ABBV-8736
  • Phase
    Phase 1
    Sex
    Female & Male
    Age
    18 - 60 Years

    Protocol Summary

    The purpose of this study is to assess the pharmacokinetics (PK), bioavailability, immunogenicity, safety, and tolerability of ABBV-8736 following subcutaneous (SC) administration relative to intravenous (IV) administration.

    Study Locations

    Location
    Status
    Location
    CenExel ACT- Anaheim Clinical Trials /ID# 280481
    Anaheim, California, United States, 92801
    Status
    Not applicable
    Location
    Acpru /Id# 280382
    Grayslake, Illinois, United States, 60030
    Status
    Not applicable